Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Management of elderly and unfit patients with chronic lymphocytic leukemia.
Mauro FR, Salaroli A, Caputo MD, Colafigli G, Petrucci L, Campanelli M, Ferretti A, Guarini AR, Foà R. Mauro FR, et al. Among authors: colafigli g. Expert Rev Hematol. 2016 Dec;9(12):1165-1175. doi: 10.1080/17474086.2016.1254544. Epub 2016 Nov 21. Expert Rev Hematol. 2016. PMID: 27796157 Review.
Introducing biological features at diagnosis improves the relapse risk stratification in patients with acute promyelocytic leukemia treated with ATRA and chemotherapy.
Breccia M, Stefania de Propris M, Molica M, Colafigli G, Minotti C, Diverio D, Latagliata R, Guarini A, Lo-Coco F, Foà R. Breccia M, et al. Among authors: colafigli g. Am J Hematol. 2015 Sep;90(9):E181-2. doi: 10.1002/ajh.24033. Epub 2015 Jul 14. Am J Hematol. 2015. PMID: 26119985 Free article. No abstract available.
Clinical characteristics and outcome of patients with autoimmune hemolytic anemia uniformly defined as primary by a diagnostic work-up.
Mauro FR, Coluzzi S, Paoloni F, Trastulli F, Armiento D, Ferretti A, Giovannetti G, Colafigli G, Molica M, la Rocca U, De Propris MS, Caronna R, Morano G, Guarini A, Girelli G, Foà R. Mauro FR, et al. Among authors: colafigli g. Am J Hematol. 2016 Jul;91(7):E319-20. doi: 10.1002/ajh.24379. Epub 2016 Apr 24. Am J Hematol. 2016. PMID: 27059006 Free article. No abstract available.
Independent prognostic impact of CD15 on complete remission achievement in patients with acute myeloid leukemia.
Chisini M, Stefanizzi C, Ceglie T, Raponi S, Vozella F, Colafigli G, Salaroli A, D'Angiò M, Mancini M, Diverio D, Breccia M, Mancini F, Minotti C, Trisolini S, Capria S, Testi AM, Guarini A, Latagliata R, De Propris MS, Foà R. Chisini M, et al. Among authors: colafigli g. Hematol Oncol. 2017 Dec;35(4):804-809. doi: 10.1002/hon.2331. Epub 2016 Jul 12. Hematol Oncol. 2017. PMID: 27400753
Timing and deepness of response to tyrosine kinase inhibitors as a measure of potential treatment discontinuation in chronic myeloid leukemia patients managed in the real-life.
Breccia M, Colafigli G, Molica M, Scalzulli E, Diverio D, Latagliata R, Guarini A, Foà R. Breccia M, et al. Among authors: colafigli g. Am J Hematol. 2017 Dec;92(12):E668-E670. doi: 10.1002/ajh.24916. Epub 2017 Oct 19. Am J Hematol. 2017. PMID: 28960424 Free article. No abstract available.
58 results